tanshinone has been researched along with arginyl-glycyl-aspartic acid in 2 studies
Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
---|---|---|---|---|---|
1,445 | 10 | 1,033 | 4,556 | 17 | 1,799 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cai, J; Costanza, F; Fan, Z; Ji, G; Li, Q; Song, D; Wang, Y | 1 |
Dong, Z; Guo, J; Wang, Y; Xing, X; Yan, J; Zhang, G; Zhang, X | 1 |
2 other study(ies) available for tanshinone and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Targeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinoma.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Diffusion; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Nanocapsules; Oligopeptides; Polyesters; Polyethylene Glycols; Polylysine; Treatment Outcome | 2014 |
Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocard
Topics: Abietanes; Animals; Isoflavones; Lipids; Mitochondria; Myocardial Infarction; Nanoparticles; Oligopeptides; Peptides, Cyclic; Polymers; Rats | 2022 |